AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

Coop Pank invites shareholders, investors, analysts and other stakeholders to join its investor webinar, scheduled on 13 February 2025 at 9 am ...

Moldova's central bank raised its key interest rate for a second policy session in a row as the economy reels under the pressure ...

The Japanese market is trading notably higher on Thursday, extending the gains in the previous two sessions, following the broadly ...

The Singapore stock market has moved lower in two straight sessions, slipping more than 30 points or 0.8 percent along the way. The ...

JCDecaux to double the number of roadside screens in London Paris, February 5th, 2025 – SE (Euronext Paris: DEC), the number one outdoor ...

Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 3 February 2025 – Euronext, the leading pan-European market infrastructure, today announces the decision of S&P to upgrade Euronext from ...

The Company announces that on 3 February 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1328 pence per share. Further details are set out below: ...

Euro area consumers' inflation expectations for the next 12 months increased for a third straight month in December, while ...

After posting a record close the previous day, the Canadian market opened marginally up and edged higher Friday morning, but kept ...

Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) reported that its fourth quarter net income attributable to shareholders of ...

Oculis Holding AG (Nasdaq: OCS; XICE: OCS) ("Oculis” or the "Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each with a nominal value of CHF 0.01, ...